Drug facts
MoleculeVenlafaxine (Effexor XR)
Generics already compete: 25 makers on the market. 113 A-rated products from 25 makers substitute at the counter.
Effexor was first approved by the FDA on 12/28/1993 under NDA 020151; the application holder is Wyeth Pharmaceuticals Inc. The Orange Book lists NDA 020151 as discontinued.
The latest NADAC for VENLAFAXINE HCL 50 MG TABLET is $0.08 per unit (as of 10/28/2026).
Holder Wyeth Pharmaceuticals IncApplication NDA 020151Approved 12/28/1993
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Effexor patent listed in the Orange Book Orange Book
02Competition
- Generics
- 25 generic makers Orange Book
- First generic approved
- 08/03/2006 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Venlafaxine profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.08 per unitVENLAFAXINE HCL 50 MG TABLET, mid-priced of 5 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 03/21/2025Class II, Venlafaxine, Zydus Pharmaceuticals (USA) Inc FDA enforcement
04Product
- Application holder
- Wyeth Pharmaceuticals Inc Orange Book
- Application
- NDA 020151 Orange Book
- First approved
- 12/28/1993 Orange Book
- Dosage forms
- capsule, extended release; tablet; tablet, extended release
- Routes
- oral
- Status
- NDA 020151 discontinued Orange Book
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.